mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging.

Int J Mol Sci

Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3004-504 Coimbra, Portugal.

Published: September 2023

The mechanistic/mammalian target of rapamycin (mTOR), a member of the phosphoinositide 3-kinase (PI3K) related kinase family, integrates intracellular and environmental cues that coordinate a diverse set of cellular/tissue functions, such as cell growth, proliferation, metabolism, autophagy, apoptosis, longevity, protein/lipid/nucleotide synthesis, and tissue regeneration and repair [...].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487471PMC
http://dx.doi.org/10.3390/ijms241713628DOI Listing

Publication Analysis

Top Keywords

mtor signaling
4
signaling insights
4
insights cancer
4
cancer cardiovascular
4
cardiovascular diseases
4
diseases diabetes
4
diabetes aging
4
aging mechanistic/mammalian
4
mechanistic/mammalian target
4
target rapamycin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!